Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Jabbour EJ, DeAngelo DJ, Stelljes M, Stock W, et al. Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE. Cancer 2018 Jan 30. doi: 10.1002/cncr.31249.
PMID: 29381191


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016